Affordable Access

Access to the full text

Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature

Authors
  • Rowczenio, Dorota M1
  • Trojer, Hadija1
  • Russell, Tonia1
  • Baginska, Anna1
  • Lane, Thirusha1
  • Stewart, Nicola M1
  • Gillmore, Julian D1
  • Hawkins, Philip N1
  • Woo, Patricia2
  • Mikoluc, Bozena3
  • Lachmann, Helen J1
  • 1 UCL Medical School, National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK , London (United Kingdom)
  • 2 UCL, Division of Infection & Immunity, Rayne Building, 5 University Street, London, WC1E 6JF, UK , London (United Kingdom)
  • 3 Children's Teaching Hospital, Department of Pediatrics and Developmental Disorders, Waszyngtona Street 17, Bialystok, 15-224, Poland , Bialystok (Poland)
Type
Published Article
Journal
Arthritis Research & Therapy
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Feb 19, 2013
Volume
15
Issue
1
Identifiers
DOI: 10.1186/ar4171
Source
Springer Nature
Keywords
License
Yellow

Abstract

IntroductionMutations in the NLRP3 gene are associated with the dominantly inherited cryopyrin-associated periodic syndrome (CAPS). The significance of the V198M variant is unclear; it has been reported in association with various CAPS phenotypes and as a variant of uncertain consequence. The aim of this study was to characterize the clinical phenotypes and treatments in individuals with V198M assessed in a single UK center.MethodsDNA samples from 830 subjects with fever syndromes or a family history of CAPS were screened for mutations in the NLRP3 gene with polymerase chain reaction (PCR) and sequencing. A detailed medical history was available in all cases. Inflammatory disease activity was monitored monthly with measurements of serum amyloid A protein (SAA) and C-reactive protein (CRP) in symptomatic individuals.ResultsNLRP3 V198M was identified in 19 subjects. It was found in association with CAPS in five cases, in one patient with Schnitzler syndrome, in three patients who also had a nucleotide alteration in another fever gene, and in three other patients with evidence of an autoinflammatory phenotype. Seven asymptomatic individuals were detected during screening of family members.ConclusionsThe NLRP3 V198M variant shows variable expressivity and reduced penetrance. It may be associated with classical inherited or apparently sporadic CAPS and with atypical autoinflammatory disease of varying severity, intriguingly including Schnitzler syndrome. The factors that influence the pathogenic consequences of this variant remain unknown. However, the remarkable response to interleukin 1 (IL-1) blockade in all but one individual in our series confirms that their clinical features are indeed mediated by IL-1.

Report this publication

Statistics

Seen <100 times